These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

708 related items for PubMed ID: 33179890

  • 1. Nonalcoholic Fatty Liver Disease: Common Questions and Answers on Diagnosis and Management.
    Westfall E, Jeske R, Bader AR.
    Am Fam Physician; 2020 Nov 15; 102(10):603-612. PubMed ID: 33179890
    [Abstract] [Full Text] [Related]

  • 2. Mechanisms, screening modalities and treatment options for individuals with non-alcoholic fatty liver disease and type 2 diabetes.
    Hydes TJ, Summers N, Brown E, Alam U, Thomaides-Brears H, Wilding JPH, Cuthbertson DJ.
    Diabet Med; 2020 Nov 15; 37(11):1793-1806. PubMed ID: 32619031
    [Abstract] [Full Text] [Related]

  • 3. AGA Clinical Practice Update: Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Lean Individuals: Expert Review.
    Long MT, Noureddin M, Lim JK.
    Gastroenterology; 2022 Sep 15; 163(3):764-774.e1. PubMed ID: 35842345
    [Abstract] [Full Text] [Related]

  • 4. Role of Noninvasive Tests in Clinical Gastroenterology Practices to Identify Patients With Nonalcoholic Steatohepatitis at High Risk of Adverse Outcomes: Expert Panel Recommendations.
    Younossi ZM, Noureddin M, Bernstein D, Kwo P, Russo M, Shiffman ML, Younes Z, Abdelmalek M.
    Am J Gastroenterol; 2021 Feb 01; 116(2):254-262. PubMed ID: 33284184
    [Abstract] [Full Text] [Related]

  • 5. Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease.
    Castera L, Friedrich-Rust M, Loomba R.
    Gastroenterology; 2019 Apr 01; 156(5):1264-1281.e4. PubMed ID: 30660725
    [Abstract] [Full Text] [Related]

  • 6. Nonalcoholic Fatty Liver Disease Review: Diagnosis, Treatment, and Outcomes.
    Ahmed A, Wong RJ, Harrison SA.
    Clin Gastroenterol Hepatol; 2015 Nov 01; 13(12):2062-70. PubMed ID: 26226097
    [Abstract] [Full Text] [Related]

  • 7. Nonalcoholic fatty liver disease: a systematic review.
    Rinella ME.
    JAMA; 2015 Jun 09; 313(22):2263-73. PubMed ID: 26057287
    [Abstract] [Full Text] [Related]

  • 8. Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.
    Patel YA, Gifford EJ, Glass LM, Turner MJ, Han B, Moylan CA, Choi S, Suzuki A, Provenzale D, Hunt CM.
    Dig Dis Sci; 2018 Sep 09; 63(9):2259-2266. PubMed ID: 29779083
    [Abstract] [Full Text] [Related]

  • 9. Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice.
    Zhou JH, Cai JJ, She ZG, Li HL.
    World J Gastroenterol; 2019 Mar 21; 25(11):1307-1326. PubMed ID: 30918425
    [Abstract] [Full Text] [Related]

  • 10. Diagnosis and management of non-alcoholic fatty liver disease.
    Jennison E, Patel J, Scorletti E, Byrne CD.
    Postgrad Med J; 2019 Jun 21; 95(1124):314-322. PubMed ID: 31085617
    [Abstract] [Full Text] [Related]

  • 11. Noninvasive diagnosis of nonalcoholic fatty liver disease: Are we there yet?
    Alkhouri N, Feldstein AE.
    Metabolism; 2016 Aug 21; 65(8):1087-95. PubMed ID: 26972222
    [Abstract] [Full Text] [Related]

  • 12. Nonalcoholic Fatty Liver Disease and Staging of Hepatic Fibrosis.
    Engin A.
    Adv Exp Med Biol; 2024 Aug 21; 1460():539-574. PubMed ID: 39287864
    [Abstract] [Full Text] [Related]

  • 13. How Would You Manage This Patient With Nonalcoholic Fatty Liver Disease?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
    Libman H, Jiang ZG, Tapper EB, Reynolds EE.
    Ann Intern Med; 2019 Aug 06; 171(3):199-207. PubMed ID: 31382287
    [Abstract] [Full Text] [Related]

  • 14. Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH.
    Traussnigg S, Kienbacher C, Halilbasic E, Rechling C, Kazemi-Shirazi L, Hofer H, Munda P, Trauner M.
    Dig Dis; 2015 Aug 06; 33(4):598-607. PubMed ID: 26159280
    [Abstract] [Full Text] [Related]

  • 15. Therapies in non-alcoholic steatohepatitis (NASH).
    Oseini AM, Sanyal AJ.
    Liver Int; 2017 Jan 06; 37 Suppl 1(Suppl 1):97-103. PubMed ID: 28052626
    [Abstract] [Full Text] [Related]

  • 16. Medical and Surgical Treatment Options for Nonalcoholic Steatohepatitis.
    Corey KE, Rinella ME.
    Dig Dis Sci; 2016 May 06; 61(5):1387-97. PubMed ID: 26942734
    [Abstract] [Full Text] [Related]

  • 17. [An interpretation of the AASLD practice guideline on the diagnosis and management of nonalcoholic fatty liver disease in 2017].
    Nan YM, Fu N, Li WC, Kong LL, Yuan XW, Zhang SY, Liu LD, Lu Y, Cui LY.
    Zhonghua Gan Zang Bing Za Zhi; 2017 Sep 20; 25(9):687-694. PubMed ID: 29108191
    [Abstract] [Full Text] [Related]

  • 18. Current and Emerging Biomarkers and Imaging Modalities for Nonalcoholic Fatty Liver Disease: Clinical and Research Applications.
    Hydes T, Brown E, Hamid A, Bateman AC, Cuthbertson DJ.
    Clin Ther; 2021 Sep 20; 43(9):1505-1522. PubMed ID: 34400007
    [Abstract] [Full Text] [Related]

  • 19. Nonalcoholic Fatty Liver Disease and Obesity Treatment.
    Brunner KT, Henneberg CJ, Wilechansky RM, Long MT.
    Curr Obes Rep; 2019 Sep 20; 8(3):220-228. PubMed ID: 30945129
    [Abstract] [Full Text] [Related]

  • 20. Steatosis severity affects the diagnostic performances of noninvasive fibrosis tests in nonalcoholic fatty liver disease.
    Joo SK, Kim W, Kim D, Kim JH, Oh S, Lee KL, Chang MS, Jung YJ, So YH, Lee MS, Bae JM, Kim BG.
    Liver Int; 2018 Feb 20; 38(2):331-341. PubMed ID: 28796410
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.